Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
32
33
Next >
Moderna, Merck, And A Personalized Cancer Vaccine: What Does Their AACR Presentaion Tell Us?
April 16, 2023
Tickers
MRK
MRNA
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Week In Review: Pfizer Picks Sinopharm To Market 12 Of Its Novel Drugs
April 15, 2023
Tickers
PFE
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Biogen Moves Deeper In Alzheimer's With Denali
April 14, 2023
Tickers
BIIB
DNLI
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Sarepta: More Drama Or Just More Noise?
April 14, 2023
Tickers
SRPT
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Chart Of The Day: RadNet - Analysts Look For 17%+ Gains
April 12, 2023
Tickers
RDNT
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Chart Of The Day: Aldeyra - Skyrocketing
April 11, 2023
Tickers
ALDX
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Tuesday Talk: Eggs Still In The Basket
April 11, 2023
Tickers
IHF
MU
PXD
SMH
Tags
Technology
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
The Canadian Cannabis Report - Monday, April 10
April 10, 2023
Tickers
CGC
CNBS
MEDIF
MJ
Tags
Healthcare
Market News
Pharma/Biotech
From
TalkMarkets
April Is Busting Out For Healthcare And Biotech
April 10, 2023
Tickers
IBB
IHI
IWF
UNH
Tags
Market News
Healthcare
ETFs
From
TalkMarkets
European Cannabis Q1 2023 Quarterly Update
April 10, 2023
Tickers
CLVR
TLRY
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Week In Review: Suzhou Duality Out-Licenses Two ADCs To BioNTech In $1.7 Billion Deal
April 08, 2023
Tickers
AMGN
BNTX
HCM
MRK
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
"Multi-Bagger" Portfolio Down 13% In March; Still Up Almost 6% YTD
April 04, 2023
Tickers
CYBN
MNMD
MSOS
POTX
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Large Cap Biopharmaceuticals Q1 2023: In This Bullish Run Biotech Lags
April 03, 2023
Tickers
ABBV
BMY
GILD
IBB
Tags
ETFs
Healthcare
Market News
From
TalkMarkets
Our Aggressive ETF Portfolio Is Outperforming The S&P 500 By A 2-To-1 Margin
April 03, 2023
Tickers
BITO
MSOS
POTX
PSIL
Tags
Pharma/Biotech
Gold/Precious Metals
Market News
From
TalkMarkets
Largest Psychedelic Stocks -3.4% In March
April 02, 2023
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Biotech And Life Science Trades: Q1 2023 Performance By The Numbers
April 01, 2023
Tickers
EVH
HOLX
IBB
PACB
Tags
Stocks / Equities
Pharma/Biotech
ETFs
From
TalkMarkets
Week In Review: Apollomics Merges With SPAC To Support Candidates Targeting Difficult-To-Treat Cancers
April 01, 2023
Tickers
ABBV
APLM
SHJBF
YS
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Bear of the Day: BioNTech
March 28, 2023
Tickers
BNTX
PFE
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
The Canadian Cannabis Report - Monday, March 27
March 27, 2023
Tickers
CGC
CNBS
MJ
NXTTF
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Bear of the Day: Pfizer Inc.
March 27, 2023
Tickers
PFE
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Cannabis Category Performances Ranged From +8.6% To -7.0% This Week
March 25, 2023
Tickers
ACRDF
AFCG
BUD
CGC
Tags
Consumer Goods
Healthcare
Market News
From
TalkMarkets
Week In Review: HighlightLL Pharma Out-Licenses Parkinson's Treatment To Biohaven For $970 Million
March 25, 2023
Tickers
BHVN
CNTB
SBMFF
TAK
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
RenovoRx’s Principal Investigator of Phase III Clinical Trial Discusses Positive Interim Results on Patients with Locally Advanced Pancreatic Cancer on OncologyTube
March 21, 2023
Tickers
RNXT
Tags
Pharma/Biotech
Healthcare
Market News
From
TalkMarkets
Evogene Offers An Excellent Risk/Reward Ratio
March 21, 2023
Tickers
BAYRY
CTVA
DNA
EVGN
Tags
Stocks / Equities
Pharma/Biotech
Healthcare
From
TalkMarkets
Squirrel In The Matrix
March 19, 2023
Tickers
EDV
EUFN
PRX
QQQ
Tags
Hedge Funds
Gold/Precious Metals
Futures
From
TalkMarkets
An Update On The Performance Of The 7 Largest Psychedelic Stocks
March 19, 2023
Tickers
ATAI
PSIL
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Week In Review: Livzon In-Licenses GERD Therapy In $127 Million Agreement
March 18, 2023
Tickers
CALT
GRCL
IRON
PFE
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Daily Stock Analysis: Roche Holding AG
March 16, 2023
Tickers
RHHBY
Tags
Market News
Healthcare
Stocks / Equities
From
TalkMarkets
Icahn Reacts Audaciously To Illumina’s Audacity
March 15, 2023
Tickers
ILMN
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Incannex Healthcare Has World's Largest Pipeline Of Psychedelic Products
March 14, 2023
Tickers
IXHL
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.